CHEBI:53730 - remazole orange-3R

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name remazole orange-3R ChEBI ID CHEBI:53730 Definition An azo compound having a ({[(2-sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl moiety attached at position 2 of a multi-substituted naphthalene. Stars This entity has been manually annotated by the ChEBI Team. Supplier Information Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C20H17N3Na2O11S3 Net Charge 0 Average Mass 617.53700 Monoisotopic Mass 616.98206 InChI InChI=1S/C20H19N3O11S3.2Na/c1-12(24)21-15-3-2-13-10-18(36(28,29)30)19(20(25)17(13)11-15)23-22-14-4-6-16(7-5-14)35(26,27)9-8-34-37(31,32)33;;/h2-7,10-11,25H,8-9H2,1H3,(H,21,24)(H,28,29,30)(H,31,32,33);;/q;2*+1/p-2/b23-22+;; InChIKey DHHGSXPASZBLGC-VPMNAVQSSA-L SMILES [Na+].[Na+].CC(=O)Nc1ccc2cc(c(\N=N\c3ccc(cc3)S(=O)(=O)CCOS([O-])(=O)=O)c(O)c2c1)S([O-])(=O)=O Roles Classification Application(s): dye View more via ChEBI Ontology ChEBI Ontology Outgoing remazole orange-3R (CHEBI:53730) has part remazole orange-3R(2−) (CHEBI:53733) remazole orange-3R (CHEBI:53730) has role dye (CHEBI:37958) remazole orange-3R (CHEBI:53730) is a monoazo compound (CHEBI:48959) remazole orange-3R (CHEBI:53730) is a organic sodium salt (CHEBI:38700) remazole orange-3R (CHEBI:53730) is a sulfone (CHEBI:35850) IUPAC Name disodium 6-acetamido-4-hydroxy-3-[(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]naphthalene-2-sulfonate Synonyms Sources Brilliant orange 3R ChemIDplus Reactive orange 16 ChEBI Reactive Orange 4 ChEBI Remazol Brilliant Orange 3R ChEBI Remazol Orange G ChEBI Registry Numbers Types Sources 20262-58-2 CAS Registry Number ChemIDplus 8819776 Reaxys Registry Number Reaxys 8819776 Beilstein Registry Number Beilstein Citations Types Sources 11696055 PubMed citation Europe PMC 16758470 PubMed citation Europe PMC 19345978 PubMed citation Europe PMC 19647934 PubMed citation Europe PMC 19733965 PubMed citation Europe PMC 22531430 PubMed citation Europe PMC 24360991 PubMed citation Europe PMC Last Modified 25 August 2023